Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women
Pilot Study for Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women
2 other identifiers
observational
250
1 country
1
Brief Summary
Background: Heart disease is a leading cause of death in the United States. Healthy diet and exercise improve heart health. Some features of where a person lives can lead to stress and decrease chances for exercise. Researchers want to see how these factors may increase the risk of heart disease in women. Objective: To see if there are differences in stress levels between women who live in different parts of Washington, DC. Also, to see how these women use their neighborhoods for exercise. Eligibility: Healthy white or black females ages 19-45 who live in Washington, DC, who have access to a smartphone Design: Participants may stay at the NIH Clinical Center overnight for a 2-day visit. Visit 1 will include: Physical exam Blood tests Electrocardiogram: Electrodes on the participant s skin will measure heart activity. PET/CT scan: Participants will get an injection. They will lie in a machine that takes pictures of the body. Surveys Body size measurements Nutrition consultation Blood vessel tests: This is measured with blood pressure cuffs, a device placed on the participant s fingertip, and a probe placed on the participant s neck. Resting Energy Expenditure: Participants will breathe under a clear hood for 45 minutes. Participants will be followed for about 2 weeks. They will wear a device on the wrist and carry a GPS device. Through a mobile app, they will answer short daily surveys on stress and exercise. Visit 2- Device return Nutritional consultation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2019
CompletedFirst Posted
Study publicly available on registry
July 10, 2019
CompletedStudy Start
First participant enrolled
October 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 26, 2026
June 5, 2026
June 3, 2026
5.1 years
July 9, 2019
June 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stress-related neural activity
Stress-related neural activity will be estimated by neuroimaging (18-FDG PET/CT amygdala activity)
1 month
Secondary Outcomes (1)
1) examine associations between neighborhood environment conditions
1 month
Study Arms (1)
Female
Diagnostic
Eligibility Criteria
Recruitment will take place at both the NIH Clinical Center and at the NHLBI Hope Center. The proposed study will be cross-sectional with a sample of healthy White females (n=30) and healthy Black females of African descent (n=30) in Washington, DC. Participants will be asked to wear a GPS unit and accelerometer, and to use a smartphone (i.e., to measure perceived stress/mood via EMA) to examine associations between GIS-derived neighborhood variables, stress-related neural activity measures, and adverse biological markers. A sample of the women (n=30) will be recruited from the high SES census tracts within Washington, DC. The other participants (n=30) will be recruited from low SES census tracts in Washington DC. Finally, participants from high and low SES census tracts in Washington DC will be matched with respect to age, race, and body mass index \[BMI\].
You may qualify if:
- Individuals eligible for this protocol:
- A healthy self-identified White female (i.e. self-identifies as White or of European descent) or healthy Black female (i.e. self-identifies as Black, African American, or of African descent)
- Must be between 19 to 45 years of age
- Must not have any chronic health condition (i.e.: cardiovascular, autoimmune, endocrinologic), or active infection
- Must be living in Washington, DC
- Must have access to a smartphone
- Must be able to provide informed consent
- Must speak English.
You may not qualify if:
- Pregnant or breast feeding
- Physically unable to perform physical activity for any reason
- Subject had weight changes greater than 20% over the past 3 months
- Subject is obese by our measurements (BMI greater than or equal to 35.0 kg/m\^2)
- If you have high or low blood pressure requiring medications
- Diabetes
- History of severe mental illnesses, treated with hospitalization
- If you have evidence of active thyroid disease requiring medications
- If you are taking medication for chronic non-mental health related illness (ie: cardiovascular, autoimmune, endocrinologic)
- If you have food allergies or highly restrictive diets that may prevent your ability to consume a controlled metabolic diet.
- If you are a current smoker (tobacco products)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Tiffany M Powell-Wiley, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2019
First Posted
July 10, 2019
Study Start
October 20, 2021
Primary Completion (Estimated)
December 10, 2026
Study Completion (Estimated)
December 26, 2026
Last Updated
June 5, 2026
Record last verified: 2026-06-03